n.a. (NEOP)

0.00
OTC BB
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange OTC BB
Shares Outstanding 3.00M
Div & Yield N.A. (N.A)

Neoprobe Initiates Third Phase 3 Lymphoseek Study

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek ® (NEO3-09) has...

Neoprobe Recommended For $1 Million Lymphoseek Grant From Ohio Third Frontier

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that Ohio’s Third Frontier Commission has voted to award a grant of $1 million to...

Neoprobe Completes Senior Debt And Preferred Stock Exchanges

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that Platinum-Montaur Life Sciences, LLC (Montaur) has agreed to exchange all $10 million...

Neoprobe Retains Makovsky + Company For Strategic Communications & Investor Relations Program

Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that it has retained Makovsky + Company, a leading global, independent public relations,...

Neoprobe Nominates Brendan Ford And Dr. Eric Rowinsky To Board

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that its Board of Directors has nominated Brendan A.

Neoprobe Device Featured In Breast Cancer Localization Procedure

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that its gamma radiation detection system product line, which includes the neo2000 ®...

Neoprobe To Present At Rodman & Renshaw Conference

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that its Vice President, Finance and Chief Financial Officer, Brent Larson, will present...

Neoprobe Announces First Quarter Results

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced consolidated results for the first quarter of 2010.

Neoprobe 1st Quarter Earnings Conference Call Invitation

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced it would report its financial results for the first quarter of 2010 on...

Neoprobe To Present At Future Leaders In Biotech Conference

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that its President and CEO, David Bupp, will present at the upcoming...

Neoprobe To Present At Roth Capital Partners 22nd Annual OC Growth Stock Conference

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that its President and CEO, David Bupp, will present at the Roth Capital Partners...

Neoprobe To Present At BIO CEO Conference

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Tuesday,...